Condition
Nodal Marginal Zone Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Nodal Marginal Zone Lymphoma clinical trials that are recruiting, at sites in 18 countries (most in United States (5), France (2), Italy (2)). By phase: Phase 1 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 18Countries
Newest Nodal Marginal Zone Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Nemtabrutinib plus rituximab for marginal zone lymphoma | Phase 2 | Duarte, California | Recruiting | May 13, 2026 |
| Epcoritamab for newly diagnosed marginal zone lymphoma | Phase 2 | Miami, Florida | Recruiting | Jan 28, 2025 |
| Improving disease understanding and outcome prediction in nodal marginal zone lymphoma | — | Miami, Florida and 49 other locations | Recruiting | Jan 26, 2023 |
| Evaluating SGR-1505 for treating mature B-cell neoplasms | Phase 1 | Gilbert, Arizona and 35 other locations | Recruiting | Sep 16, 2022 |
| Treatment using modified T cells for certain types of lymphoma | Phase 1 | Chapel Hill, North Carolina | Recruiting | Jan 10, 2020 |
All recruiting trials (5)
-
Nemtabrutinib plus rituximab for marginal zone lymphoma
This phase 2 trial tests whether combining nemtabrutinib with rituximab can help people with marginal zone lymphoma.
-
Epcoritamab for newly diagnosed marginal zone lymphoma
This trial will test whether the antibody drug epcoritamab helps adults who are newly diagnosed with marginal zone lymphoma.
-
Improving disease understanding and outcome prediction in nodal marginal zone lymphoma
This study is trying to better understand nodal marginal zone lymphoma by collecting and analyzing patient data and tumor samples from people diagnosed with the disease since 2000.
-
Evaluating SGR-1505 for treating mature B-cell neoplasms
This study is testing a new oral medication called SGR-1505 to see if it is safe and effective for people with certain types of B-cell lymphomas that have not responded to other treatments.
-
Treatment using modified T cells for certain types of lymphoma
This study is testing a new treatment using modified immune cells to see if it can help people with certain types of lymphoma that haven't responded to other therapies.
Related topics
Quick answers
How many Nodal Marginal Zone Lymphoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in United States (5 trials), France (2 trials), Italy (2 trials), Poland (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.